Breaking News

AbbVie Breaks Ground on Chicago API Manufacturing Plant

Will enable AbbVie to relocate API production for select products from Europe and Asia to the U.S.

Author Image

By: Charlie Sternberg

Associate Editor

AbbVie officials participate in a groundbreaking ceremony for AbbVie’s new active pharmaceutical ingredient (API) facility in North Chicago, Illinois.

AbbVie has started construction of its new active pharmaceutical ingredient (API) manufacturing plant in North Chicago, Illinois. “Today’s groundbreaking is an important milestone in AbbVie’s ongoing campaign to accelerate biopharmaceutical innovation and manufacturing capabilities in the U.S.,” said Azita Saleki-Gerhardt, Ph.D., executive vice president and chief operations officer, AbbVie. “Over the next decade, AbbVie plans to invest more than $10 billion in c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters